Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in Pulmonary Arterial Hypertension (EVALUATION)
NCT00718952Phase 3Completed
- Sponsor
- Tongji University
- Start
- Jul 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vardenafil in pulmonary arterial hypertension (PAH), sponsored by Tongji University. Started Jul 2008; status: completed.
02
Drugs
vardenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00718952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718952.